ECDOC_100393581.pdf
PHAG_Cons. EU DoC_MDR_Class I
Foliodrape podložka pod pacienta
Foliodrape® Patient underlayer for OR table, non-sterile is a disposable, single use product.
Foliodrape® Patient underlayer for OR table, non-sterile covers the OR-Table prior positioning the patient on it. It absorbs patient fluids and reduces the risk of cross contamination between patients treated in sequential interventions, while supporting the change over process.
The product is in Medical Device class 1 and is intended for use by healthcare professionals.
Foliodrape podložka pod pacienta
Foliodrape® Patient underlayer for OR table, non-sterile is a disposable, single use product with direct contact to the skin for limited use for covering the OR-Table prior positioning the patient on it. It absorbs the patient fluids and reduces risk of cross contamination between patients treated in sequential interventions, while supporting the change over process.
Foliodrape® Patient underlayer for OR table, non-sterile is in Medical Device class I.Foliodrape® Patient underlayer for OR table, non-sterile fufills all requirements equivalent to European standard EN 13795-1:2019 for the standard performance level “Standard performance, critical area” in the non-woven area of the product. Additional details on product performance can be found in the Technical Data Sheet. Product is intended for use by healthcare professionals.
Non-sterile products packed together into a PE bag and placed into outer carton
Informace o produktech | číslo výrobku | Obsah | EAN | ||
Non-sterile products packed together into a PE bag and placed into outer carton | |||||
220 x 100 cm |
|
1 karton á 40 ks | 4052199582238 |
Foliodrape® Patient underlayer for OR table, non-sterile is made of 3-layers of material.
Foliodrape® Patient underlayer may be used in preparation of any type of surgery. Depending on the procedure for which it is used, the product's usage time* will vary from a few minutes to several hours of continuous usage.
* Definitions according to Reg. (EU) 2017/745 (MDR)